Barrington Research Maintains Outperform on HealthEquity, Announces $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Alexander Paris maintains an Outperform rating on HealthEquity (NASDAQ:HQY) and sets a price target of $100.
March 22, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity maintains its Outperform rating by Barrington Research with a new price target of $100.
The maintenance of an Outperform rating combined with a significant price target of $100 by a reputable analyst firm like Barrington Research is likely to instill confidence among investors and could lead to a positive short-term price movement for HealthEquity's stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100